Mustang Bio, Inc. (MBIO)
0.5412
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Mustang Bio Shareholders Equity (Quarterly) : 7.545M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.545M |
| March 31, 2026 | 8.596M |
| December 31, 2025 | 9.529M |
| September 30, 2025 | 9.771M |
| June 30, 2025 | 2.892M |
| March 31, 2025 | 3.609M |
| December 31, 2024 | -3.873M |
| September 30, 2024 | -8.656M |
| June 30, 2024 | -8.33M |
| March 31, 2024 | -4.943M |
| December 31, 2023 | 0.123M |
| September 30, 2023 | 4.009M |
| June 30, 2023 | 13.71M |
| March 31, 2023 | 29.82M |
| December 31, 2022 | 46.27M |
| September 30, 2022 | 64.32M |
| June 30, 2022 | 82.01M |
| March 31, 2022 | 97.33M |
| December 31, 2021 | 112.40M |
| September 30, 2021 | 122.21M |
| June 30, 2021 | 135.02M |
| Date | Value |
|---|---|
| March 31, 2021 | 133.36M |
| December 31, 2020 | 98.44M |
| September 30, 2020 | 76.42M |
| June 30, 2020 | 71.03M |
| March 31, 2020 | 45.80M |
| December 31, 2019 | 51.65M |
| September 30, 2019 | 62.45M |
| June 30, 2019 | 71.44M |
| March 31, 2019 | 28.48M |
| December 31, 2018 | 36.40M |
| September 30, 2018 | 44.99M |
| June 30, 2018 | 51.60M |
| March 31, 2018 | 55.64M |
| December 31, 2017 | 59.83M |
| September 30, 2017 | 65.09M |
| June 30, 2017 | 69.07M |
| March 31, 2017 | 74.21M |
| December 31, 2016 | 24.28M |
| September 30, 2016 | 3.322M |
| June 30, 2016 | -6.165M |
| March 31, 2016 | -5.032M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.61M |
| Total Liabilities (Quarterly) | 8.068M |
| Current Ratio | 1.972 |